The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Small-Cell Carcinomas of the Gastrointestinal Tract: A Review
Abstract
Purpose: To improve our understanding of the entity of small-cell carcinoma (SmCC) of the gastrointestinal (GI) tract. Methods: A MEDLINE search was done, using the terms “small cell carcinoma” or “oat cell carcinoma” combined with “gastrointestinal” or with any of the GI sites, for the period 1970 to 2003. The 138 eligible reports identified in this way were reviewed for clinical data. Results: To date, approximately 544 cases of GI SmCC have been reported. The disease represents 0.1% to 1% of all GI malignancies, with the esophagus being the most common primary site. A majority of patients present with overt distant metastases. Systemic symptoms are common; ectopic hormonal secretion may occur. By light microscopy, GI SmCCs are essentially indistinguishable from primary pulmonary SmCC. The presence of non-SmCC components is common. Data from molecular analysis of the disease has identified some similarities to pulmonary SmCC. Chemotherapy represents the main treatment option, with modest impact on survival. In locoregional disease, the literature suggests that treatment be initiated using chemoradiotherapy and then, if metastatic disease is still excluded, surgical resection be considered. The disease is highly aggressive, and survival is in the range of several weeks for untreated patients and of 6 to 12 months for those receiving therapy. Conclusion: SmCC of the GI tract is a rare and lethal disease. Although there are many similarities to pulmonary SmCC, some differences between the two entities are suggested. While chemotherapy can achieve significant palliation, surgery may have a potential impact on long-term survival of patients with locoregional disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., & Johnson, D. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400403 · Cited by 1,506
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
Pignon, J.-P., Arriagada, R., Ihde, D. C., Johnson, D. H., Perry, M. C., Souhami, R. L., Brodin, O., Joss, R. A., Kies, M. S., Lebeau, B., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272302 · Cited by 1,331
Warde, P., & Payne, D. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.890 · Cited by 816
Keynote address on biostatistics and data retrieval.
Zelen, M. (1973) · PubMed · Cited by 482
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung
Perry, M. C., Eaton, W. L., Propert, K. J., Ware, J. H., Zimmer, B., Chahinian, A. P., Skarin, A., Carey, R. W., Kreisman, H., Faulkner, C., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161504 · Cited by 482
Molecular genetics of small cell lung carcinoma
WISTUBA, I. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90072-7 · Cited by 421
Ordóñez, N. G. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200009000-00004 · Cited by 337
BUNN, P. A., LICHTER, A. S., MAKUCH, R. W., COHEN, M. H., VEACH, S. R., MATTHEWS, M. J., ANDERSON, A. J., EDISON, M., GLATSTEIN, E., MINNA, J. D., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-655 · Cited by 225
Extrapulmonary Small-Cell Carcinoma: A REVIEW OF THE LITERATURE WITH EMPHASIS ON THERAPY AND OUTCOME
REMICK, S. C., HAFEZ, G. R., & CARBONE, P. P. (1987) · Medicine · doi:10.1097/00005792-198711000-00004 · Cited by 175
Kaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153
Ge, R., & Johnson, B. E. (1993) · PubMed · Cited by 139
Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases.
Matsui, K., Kitagawa, M., Miwa, A., et al. (1991) · PubMed · Cited by 122
Arriagada, R., Kramar, A., Chevalier, T. L., & de Crémoux, H. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.3.447 · Cited by 107
Small Cell Carcinoma of the Gallbladder
Maitra, A., Tascilar, M., Hruban, R. H., Offerhaus, G. J. A., & Albores‐Saavedra, J. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00005 · Cited by 98
Malignant gastric neuroendocrinomas
Chejfec, G., & Gould, V. E. (1977) · Human Pathology · doi:10.1016/s0046-8177(77)80007-5 · Cited by 86
Adjuvant and neoadjuvant therapy in prostate cancer
Chay, C. H. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90041-7 · Cited by 35
Telomerase activity in small cell esophageal carcinoma
Chow, V., Law, S. Y.-K., Lam, A. K.-Y., Luk, J. M., & Wong, J. S. L. (2001) · Diseases of the Esophagus · doi:10.1046/j.1442-2050.2001.00172.x · Cited by 25
Cited by
Sorbye, H., Welin, S., Langer, S. W., Vestermark, L. W., Holt, N., Osterlund, P., Dueland, S., Hofsli, E., Guren, M. G., Ohrling, K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds276 · Cited by 1,027
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ganti, A. K. P., Loo, B. W., Bassetti, M., Blakely, C., Chiang, A., D'Amico, T. A., D'Avella, C., Dowlati, A., Downey, R. J., Edelman, M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0058 · Cited by 486
Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. Q., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0011 · Cited by 436
Gastroenteropancreatic high‐grade neuroendocrine carcinoma
Sorbye, H., Strosberg, J., Baudin, E., Klimstra, D. S., & Yao, J. C. (2014) · Cancer · doi:10.1002/cncr.28721 · Cited by 347
Self-citationClassification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Klöppel, G. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0013 · Cited by 336
Metadata
- Authors
- Brenner, B., Tang, L. H., Klimstra, D. S., & Kelsen, D. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-07-01
- Volume
- 22
- Issue
- 13
- Pages
- 2730-2739
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2011761477
- Cited by
- 294
- References
- 17
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.